Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Jul 2025
A Flinders University study shows that bowel cancer survivors face an elevated risk of developing multiple primary cancers (MPCs)—for prostate, lung, breast and blood cancer.
Read Full NewsA novel oral ketamine drug shows a signal for reducing depressive symptoms with minimal dissociative effects.
Men who receive personalized estimates of the likelihood of raised prostate-specific antigen levels are more likely to decide to get screening than those who receive general information on pros and cons.
Upadacitinib and infliximab offer rapid relief from symptoms in biologic-naive patients with moderate-to-severe ulcerative colitis.
Clinicians and patients are already relying on AI, while hospitals are still building the oversight to keep up.
A culturally tailored lifestyle program improves cognition significantly more than standard health advice among older adults at risk for dementia across Latin America.
People with intellectual disabilities who have physical health problems or sensory impairments face a higher risk for challenging behaviours.
Rimegepant is safe and effective in patients with migraine not responding to multiple prior preventive therapies, a real-world study shows.
1.
Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain
2.
In prostate cancer survivorship, sleep disturbances are underappreciated.
3.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
4.
Breast Cancer Genetic Testing Need in Black Women Identified
5.
Drugmaker Pulls Trodelvy's Bladder Cancer Approval
1.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
2.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
3.
The Ins and Outs of Glossectomy: What You Need to Know
4.
Understanding Hidrocystoma: Symptoms, Causes, and Treatment Options
5.
Understanding Neutrophilia: Causes, Symptoms, and Treatment Options
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
3.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge